[
    {
        "title": "Santos-Faria D. Tocilizumab and rituximab have similar effectiveness and are both superior to a second tumour necrosis factor inhibitor (TNFi) in rheumatoid arthritis patients who discontinued a first TNFi. \u00d3RG\u00c3O OfICIAL dA SOCIEdAdE PORTUGUESA dE REUMATOLOGIA. 2019;44:103-13.",
        "paper_uid": "05c073e4",
        "reference": "Santos-Faria D. Tocilizumab and rituximab have similar effectiveness and are both superior to a second tumour necrosis factor inhibitor (TNFi) in rheumatoid arthritis patients who discontinued a first TNFi. \u00d3RG\u00c3O OfICIAL dA SOCIEdAdE PORTUGUESA dE REUMATOLOGIA. 2019;44:103-13.",
        "save_folder_path": null,
        "study_design": "Observational Study"
    }
]